In addition, recruitment of study subjects can be easier in developing countries, where a trialsubject may get more than a year's pay to participate or participation could be his or her sole means of being able to get treatment, the authors said.
Viral loads of the patients remained stable or decreased during the nine month trial - and one subject showed a sustained dramatic decrease in viral load.